The molecular basis and therapeutic aspects of cisplatin resistance in oral squamous cell carcinoma

Y Cheng, S Li, L Gao, K Zhi, W Ren - Frontiers in oncology, 2021 - frontiersin.org
Oral squamous cell carcinoma (OSCC) is a kind of malignant tumors with low survival rate
and prone to have early metastasis and recurrence. Cisplatin is an alkylating agent which …

Major molecular signaling pathways in oral cancer associated with therapeutic resistance

S Usman, A Jamal, MT Teh, A Waseem - Frontiers in Oral Health, 2021 - frontiersin.org
Oral cancer is a sub-category of head and neck cancers that primarily initiates in the oral
cavity. The primary treatment option for oral cancer remains surgery but it is associated with …

[HTML][HTML] Single-cell transcriptomics of human islet ontogeny defines the molecular basis of β-cell dedifferentiation in T2D

D Avrahami, YJ Wang, J Schug, E Feleke, L Gao… - Molecular …, 2020 - Elsevier
Objective Dedifferentiation of pancreatic β-cells may reduce islet function in type 2 diabetes
(T2D). However, the prevalence, plasticity and functional consequences of this cellular state …

Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells

P Meng, YF Zhang, W Zhang, X Chen, T Xu, S Hu… - Scientific reports, 2021 - nature.com
Abstract Glypican-3 (GPC3) is a cell surface heparan sulfate proteoglycan that is being
evaluated as an emerging therapeutic target in hepatocellular carcinoma (HCC). GPC3 has …

Connecting the dots: investigating the link between environmental, genetic, and epigenetic influences in metabolomic alterations in oral squamous cell carcinoma

I Gupta, F Badrzadeh, Y Tsentalovich… - Journal of Experimental & …, 2024 - Springer
Oral squamous cell carcinoma (OSCC) accounts for around 90% of all oral cancers and is
the eighth most common cancer worldwide. Despite progress in managing OSCC, the …

Update on chemoresistance mechanisms to first-line chemotherapy for gallbladder cancer and potential reversal strategies

J Lai, S Yang, Z Lin, W Huang, X Li, R Li… - American journal of …, 2023 - journals.lww.com
Objective: Gallbladder cancer (GBC) mortality remains high and chemoresistance is
increasing. This review consolidates what is known about the mechanisms of …

The FAT1 cadherin drives vascular smooth muscle cell migration

DF Riascos-Bernal, G Ressa, A Korrapati, NES Sibinga - Cells, 2023 - mdpi.com
Vascular smooth muscle cells (VSMCs) are normally quiescent and non-migratory,
regulating the contraction and relaxation of blood vessels to control the vascular tone. In …

FAT1 Upregulates in Oral Squamous Cell Carcinoma and Promotes Cell Proliferation via Cell Cycle and DNA Repair

T Lan, Q Ge, K Zheng, L Huang, Y Yan, L Zheng… - Frontiers in …, 2022 - frontiersin.org
Objective Previous studies have revealed that FAT atypical cadherin 1 (FAT1) plays a tumor-
suppressive or oncogenic role in a context-dependent manner in various cancers. However …

[HTML][HTML] Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review

F Atashi, N Vahed, P Emamverdizadeh… - Journal of Dental …, 2021 - ncbi.nlm.nih.gov
Head and neck cancers are highly prevalent worldwide. Most of these lesions are
diagnosed in the advanced stages of the disease. Thus, they do not often have a good long …

WNT7A promotes EGF-induced migration of oral squamous cell carcinoma cells by activating β-catenin/MMP9-mediated signaling

H Xie, Y Ma, J Li, H Chen, Y Xie, M Chen… - Frontiers in …, 2020 - frontiersin.org
Aims and hypothesis Epidermal growth factor (EGF) has been shown to induce the migration
of various cancer cells. However, the underlying signaling mechanisms for EGF-induced …